{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:40:30Z","timestamp":1789958430335,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023312","name":"Wellcome EPSRC Centre for Medical Engineering","doi-asserted-by":"publisher","award":["WT 203148\/Z\/16\/Z"],"award-info":[{"award-number":["WT 203148\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100023312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021170","name":"Brain Tumour Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000762","name":"Imperial College Healthcare NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canep.2025.102811","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:34:36Z","timestamp":1744166076000},"page":"102811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Adult glioblastoma in England: Incidence, treatment, and outcomes with novel population-based strata"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1965-2661","authenticated-orcid":false,"given":"Kerlann","family":"Le Calvez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radvile","family":"Mauricaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-707X","authenticated-orcid":false,"given":"Andrew","family":"Brodbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-780X","authenticated-orcid":false,"given":"Jonathan J.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Dadhania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5268-0771","authenticated-orcid":false,"given":"Lillie","family":"Pakzad-Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1745-6074","authenticated-orcid":false,"given":"Maureen","family":"Dumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingela","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Basharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canep.2025.102811_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18222","article-title":"International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of disease","volume":"9","author":"Ilic","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.canep.2025.102811_bib2","article-title":"URL","author":"Cancer Research UK","year":"2024","journal-title":"Cancer Incid. all Cancers Comb."},{"issue":"2","key":"10.1016\/j.canep.2025.102811_bib3","first-page":"1","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010","volume":"15 2","author":"Ostrom","year":"2013","journal-title":"Neuro-oncology"},{"issue":"2","key":"10.1016\/j.canep.2025.102811_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjc.6602321","article-title":"Years of life lost (YLL) from cancer is an important measure of population burden - And should be considered when allocating research funds","volume":"92","author":"Burnet","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/neuonc\/nov249","article-title":"Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010","volume":"18","author":"Rouse","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.canep.2025.102811_bib6","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know\u2014a minireview","volume":"164","author":"Sverre Helge Torp","year":"2022","journal-title":"Acta Neurochir."},{"issue":"23","key":"10.1016\/j.canep.2025.102811_bib7","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Roger Stupp","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.canep.2025.102811_bib8","first-page":"CD013261","article-title":"Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis","volume":"3","author":"Hanna","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.canep.2025.102811_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2025.102811_bib10","unstructured":"GOV.UK. National Cancer Registration and Analysis Service (NCRAS), 11 2016. URL \u3008https:\/\/www.gov\u3009. uk\/guidance\/national-cancer-registration-and-analysis-service-ncras."},{"key":"10.1016\/j.canep.2025.102811_bib11","unstructured":"NHS Digital. NHS Classifications ICD-10, 2023. URL \u3008https:\/\/isd.digital.nhs.uk\/trud\/users\/guest\/\u3009 filters\/0\/categories\/28."},{"key":"10.1016\/j.canep.2025.102811_bib12","unstructured":"NHS England. Core \u2013 Diagnostic procedures, 2023. URL \u3008https:\/\/digital.nhs.uk\/ndrs\/data\/data-sets\/\u3009 cosd\/cosd-user-guide-v10\/core---diagnostic-procedures."},{"key":"10.1016\/j.canep.2025.102811_bib13","unstructured":"Department for Communities and Local Government. The English Index of Multiple Deprivation (IMD) 2015 7 domains of deprivation The IMD ranks each small area in England. Technical Report Imd, GOV, 2015. URL \u3008https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015%0Ahttps\u3009: \/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/ 464431\/English_Index_of_Multiple_Deprivation_2015_-_Infographic.pdf%0A\u3008https:\/\/ww\u3009."},{"key":"10.1016\/j.canep.2025.102811_bib14","unstructured":"Micah Caldano, Nour Kanso, Kerlann Le Calvez, Radvile Mauricaite, and Matt Williams. Gliocova, 2022. URL \u3008https:\/\/blogs.imperial.ac.uk\/gliocova\/\u3009."},{"key":"10.1016\/j.canep.2025.102811_bib15","unstructured":"Matthew Williams. About Gliocova \u2013 GlioCova, 10 2020. URL \u3008https:\/\/wwwf.imperial.ac.uk\/blog\/\u3009 gliocova\/about-gliocova\/."},{"key":"10.1016\/j.canep.2025.102811_bib16","unstructured":"Office for National Statistics. Population denominators by ethnic group, regions and countries: England and Wales, 2011 to 2018, 2018. URL \u3008https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/adhocs\/008780populationdenominatorsbyethnicgroupregionsandcountriesenglandandwales2011to2017\u3009."},{"key":"10.1016\/j.canep.2025.102811_bib17","unstructured":"Office for National Statistics. Estimates of the population for the UK, England and Wales, Scotland and Northern Ireland, 2021. URL \u3008https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/datasets\/\u3009 populationestimatesforukenglandandwalesscotlandandnorthernireland."},{"key":"10.1016\/j.canep.2025.102811_bib18","volume":"XI","year":"2021"},{"key":"10.1016\/j.canep.2025.102811_bib19","unstructured":"eurostat European Comission. Methodologies and Working papers Revision of the European Standard Population Report of Eurostat\u2019s task force. eurostat European Comission, 2013 edition, 2013. ISBN 9789279310942. URL \u3008https:\/\/ec.europa.eu\/eurostat\/documents\/3859598\/5926869\/KS-RA-13-028-EN\u3009. PDF\/e713fa79-1add-44e8-b23d-5e8fa09b3f8f."},{"key":"10.1016\/j.canep.2025.102811_bib20","unstructured":"Office for National Statistics. Ethnic group, national identity and religion, 2016. URL \u3008https:\/\/www.ons.gov.uk\/methodology\/classificationsandstandards\/measuringequality\/\u3009 ethnicgroupnationalidentityandreligion."},{"key":"10.1016\/j.canep.2025.102811_bib21","unstructured":"Georgia Butterworth and Yasmin Al-haboubi. Integrated care systems explained: making sense of the new NHS structure. Technical Report April 2022, NHS, 2021. URL \u3008https:\/\/nhsproviders.org\/media\/691164\/system-working-glossary-for-governors.pdf\u3009."},{"issue":"45","key":"10.1016\/j.canep.2025.102811_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7748\/ns1999.07.13.45.32.c2650","article-title":"The Delphi technique","volume":"13","author":"Bowles","year":"1999","journal-title":"Nurs. Stand. (R. Coll. Nurs. (Gt. Br. ): 1987)"},{"issue":"4","key":"10.1016\/j.canep.2025.102811_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: How to decide its appropriateness","volume":"11","author":"Prashant Nasa","year":"2021","journal-title":"World J. Methodol."},{"key":"10.1016\/j.canep.2025.102811_bib24","unstructured":"Python. Python, 2018. URL \u3008https:\/\/www.python.org\/\u3009."},{"key":"10.1016\/j.canep.2025.102811_bib25","unstructured":"SQLite. SQLite Home Page, 2021. URL \u3008https:\/\/www.sqlite.org\/index.html\u3009."},{"key":"10.1016\/j.canep.2025.102811_bib26","unstructured":"RStudio. RStudio, 2019. URL \u3008https:\/\/www.rstudio.com\/\u3009."},{"key":"10.1016\/j.canep.2025.102811_bib27","unstructured":"NHS Digital. NHS Maternity Statistics in England in 2020-21, 2021. URL \u3008https:\/\/digital\u3009. nhs.uk\/data-and-information\/publications\/statistical\/nhs-maternity-statistics\/2020-21\/ deliveries---2021-hes#method-of-delivery-postnatal-stay."},{"issue":"4","key":"10.1016\/j.canep.2025.102811_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejca.2014.12.014","article-title":"Glioblastoma in England: 2007-2011","volume":"51","author":"Brodbelt","year":"2015","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12967-019-1859-6","article-title":"The French glioblastoma biobank (FGB): a national clinicobiological database","volume":"17","author":"Clavreul","year":"2019","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.canep.2025.102811_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/neuonc\/noy195","article-title":"Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013","volume":"21","author":"Walker","year":"2019","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.canep.2025.102811_bib31","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/0284186X.2019.1603396","article-title":"Incidence trends of adult malignant brain tumors in Finland, 1990\u20132016","volume":"58","author":"Natukka","year":"2019","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.canep.2025.102811_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000222090","article-title":"Descriptive epidemiology of cerebral gliomas in northwest Greece and study of potential predisposing factors, 2005-2007","volume":"33","author":"Gousias","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"11","key":"10.1016\/j.canep.2025.102811_bib33","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00432-021-03596-5","article-title":"Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries","volume":"147","author":"Efremov","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2025.102811_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN\u2013a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Gerda Engholm","year":"2010","journal-title":"Acta Oncol. (Stockh., Swed. )"},{"issue":"4","key":"10.1016\/j.canep.2025.102811_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/0284186X.2017.1407039","article-title":"Nordic cancer registries \u2013 an overview of their procedures and data comparability","volume":"57","author":"Pukkala","year":"2018","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1078-0432.CCR-11-2073","article-title":"Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma","volume":"18","author":"Tsien","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canep.2025.102811_bib37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/neuonc\/noy002","article-title":"Females have the survival advantage in glioblastoma","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.canep.2025.102811_bib38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult glioma incidence and survival by race or ethnicity in the United States From 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.canep.2025.102811_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/nop\/npz059","article-title":"Relative survival after diagnosis with a primary brain or other central nervous system tumor in the national program of cancer registries, 2004 to 2014","volume":"7","author":"Quinn","year":"2020","journal-title":"Neuro-Oncol. Pract."},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-018-03065-z","article-title":"Association of patterns of care, prognostic factors, and use of radiotherapy\u2013temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study","volume":"142","author":"Fabbro-Peray","year":"2019","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nop\/npy014","article-title":"Patterns and disparities of care in glioblastoma","volume":"6","author":"Dressler","year":"2019","journal-title":"Neuro-Oncol. Pract."},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/nop\/npac069","article-title":"Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period","volume":"10","author":"Woo","year":"2023","journal-title":"Neuro-Oncol. Pract."},{"issue":"12","key":"10.1016\/j.canep.2025.102811_bib43","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/cncr.21539","article-title":"A populationbased description of glioblastoma multiforme in Los Angeles County, 1974-1999","volume":"104","author":"Indro Chakrabarti","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.canep.2025.102811_bib44","first-page":"179","article-title":"Socioeconomic status and glioblastoma risk: a population-based analysis","volume":"26","author":"Porter","year":"2015","journal-title":"Cancer Causes Control. Control.: CCC"},{"issue":"10","key":"10.1016\/j.canep.2025.102811_bib45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.canep.2025.102811_bib46","article-title":"Resection and survival data from a clinical trial of glioblastoma multiforme-specific IRDye800-BBN fluorescence-guided surgery","volume":"6","author":"Kunshan He","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"4","key":"10.1016\/j.canep.2025.102811_bib47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma clinical trials: current landscape and opportunities for improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:23:39Z","timestamp":1769588619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S1877782125000712"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102811","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult glioblastoma in England: Incidence, treatment, and outcomes with novel population-based strata","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102811"}}